Among the 238 common hot-spot cancer mutations in 19 genes interrogated by the OncoCarta panel, mutations were detected in 7 different genes at 26 different nucleotide positions in our colon cancer samples.
Bottom panels: mutations detected in Sanger sequenced yeast clones unmodified or harbouring a chimeric YBR194W-snR6 locus.
Each panel allowed mutation detection of core cancer genes including KRAS, BRAF, and EGFR.
A large panel of Mutation Accumulation (MA) lines is scored for allele length at fifty-four perfect dinucleotide repeat loci.
In the left panel, low mutation rates generate only low levels of background selection and values of D2and D3are strongly correlated, as both are due to clonal interference.
For these, a large panel of mutation positive and other sequence variant controls were used to test the ability of the amplicons to identify sequence variants.
Middle panel, the mutation frequency plotted as a function of the indicated lesion on the top strand of FM1 for the cells transfected with siCtrl (control siRNA), siA3B, siA3F, siA3C, siA3B and siA3F, or all three.
A panel of mutations was introduced into residues substantially displaced upon the G93A mutation.
For this analysis, we defined negative as those samples that proved to be negative for the panel of mutations, i.e., BRAF V600E, NRAS Q61R, IDH1 mutations and RET/PTC rearrangements.
The panel of mutations contained, among others, the most prevalent mutant CBS alleles to well represent the molecular mechanisms relevant for the majority of patients suffering from CBS deficiency.
